IBEX Stock Analysis: IBEX | NASDAQ
Information Technology Services | NASDAQ, USA | Market Cap: 445m USD | 12M Return: 7.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.49M
EPS Trend: 96.3%
Qual. Beats: 4
Rev. Trend: 84.7%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 5.9 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
IBEX Limited (NASDAQ: IBEX) is a technology-enabled provider of end-to-end customer lifecycle experience (CX) solutions, operating customer engagement and customer acquisition delivery centers in the United States and internationally. Its offering is organized around three core brands: ibex Connect (omnichannel outsourced customer service, technical support, and back-office operations), ibex Digital (digital marketing and e-commerce customer acquisition), and ibex CX (a software suite for measuring and managing customer experiences). The company is headquartered in Washington, D.C., was incorporated in 2017, and went public in August 2020.
IBEX operates within the broader business process outsourcing (BPO) and contact-center-as-a-service industry, where competitors typically combine offshore delivery infrastructure with proprietary software to handle large-volume customer interactions. GICS classifies the company within the Information Technology sector under Application Software, reflecting the software-driven nature of its CX platform, while its revenue model is anchored in multi-year outsourced service contracts with clients across banking and financial services, retail and e-commerce, health tech, travel and hospitality, streaming and entertainment, delivery and logistics, high tech, and utilities.
The company was formerly known as IBEX Holdings Limited before rebranding to IBEX Limited in September 2019, and it qualifies as a small-cap stock with a market capitalization of roughly $396 million USD.
- Offshore wage inflation pressures BPO delivery center margins
- AI automation tools expand ibex CX platform productivity
- Healthcare and financial services verticals accelerate revenue growth
| Net Income: 47.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 3.69 > 1.0 |
| NWC/Revenue: 12.86% < 20% (prev 11.14%; Δ 1.73% < -1%) |
| CFO/TA 0.21 > 3% & CFO 62.1m > Net Income 47.2m |
| Net Debt (45.6m) to EBITDA (76.1m): 0.60 < 3 |
| Current Ratio: 1.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.0m) vs 12m ago 4.10% < -2% |
| Gross Margin: 28.29% > 18% (prev 30.89%; Δ -2.61% > 0.5%) |
| Asset Turnover: 219.2% > 50% (prev 195.0%; Δ 24.24% > 0%) |
| Interest Coverage Ratio: 49.56 > 6 (EBIT TTM 57.6m / Interest Expense TTM 1.16m) |
| A: 0.27 (Total Current Assets 165.4m - Total Current Liabilities 84.8m) / Total Assets 297.2m |
| B: 0.21 (Retained Earnings 63.3m / Total Assets 297.2m) |
| C: 0.20 (EBIT TTM 57.6m / Avg Total Assets 286.0m) |
| D: 1.18 (Book Value of Equity 160.8m / Total Liabilities 136.5m) |
| Altman-Z'' = 5.06 = AAA |
| DSRI: 0.90 (Receivables 131.2m/125.1m, Revenue 626.9m/535.7m) |
| GMI: 1.09 (GM 30.89% / 28.29%) |
| AQI: 1.08 (AQ_t 0.12 / AQ_t-1 0.11) |
| SGI: 1.17 (Revenue 626.9m / 535.7m) |
| TATA: -0.05 (NI 47.2m - CFO 62.1m) / TA 297.2m) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of July 10, 2026, the stock is trading at USD 32.85 with a total of 84,531 shares traded. Over the past week, the price has changed by +3.96%, over one month by +8.17%, over three months by +18.21% and over the past year by +7.18%.
Current recommended Stop Loss: 31.40 (which is 4.4% or 1.3 ATR below the current price).
IBEX has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold IBEX.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 37.5 | 14.2% |
P/E Trailing = 10.1933
P/E Forward = 9.0992
P/S = 0.7097
P/B = 2.6756
Revenue TTM = 626.9m USD
EBIT TTM = 57.6m USD
EBITDA TTM = 76.1m USD
Long Term Debt = 45.6m USD (estimated: total debt 61.0m - short term 15.4m)
Short Term Debt = 15.4m USD (from shortTermDebt, last quarter)
Debt = 61.0m USD (from shortLongTermDebtTotal, last quarter) (leases 61.0m already included)
Net Debt = 45.6m USD (calculated: Debt 61.0m - CCE 15.4m)
Enterprise Value = 490.5m USD (444.9m + Debt 61.0m - CCE 15.4m)
Interest Coverage Ratio = 49.56 (Ebit TTM 57.6m / Interest Expense TTM 1.16m)
EV/FCF = 15.18x (Enterprise Value 490.5m / FCF TTM 32.3m)
FCF Yield = 6.59% (FCF TTM 32.3m / Enterprise Value 490.5m)
FCF Margin = 5.15% (FCF TTM 32.3m / Revenue TTM 626.9m)
Net Margin = 7.53% (Net Income TTM 47.2m / Revenue TTM 626.9m)
Gross Margin = 28.29% ((Revenue TTM 626.9m - Cost of Revenue TTM 449.6m) / Revenue TTM)
Gross Margin QoQ = 26.53% (prev 26.09%)
Tobins Q-Ratio = 1.65 (Enterprise Value 490.5m / Total Assets 297.2m)
Interest Expense / Debt = 1.90% (Interest Expense 1.16m / Debt 61.0m)
Taxrate = 16.38% (9.24m / 56.4m)
NOPAT = 48.2m (EBIT 57.6m * (1 - 16.38%))
Current Ratio = 1.95 (Total Current Assets 165.4m / Total Current Liabilities 84.8m)
Debt / Equity = 0.38 (Debt 61.0m / totalStockholderEquity, last quarter 160.8m)
Debt / EBITDA = 0.60 (Net Debt 45.6m / EBITDA 76.1m)
Debt / FCF = 1.41 (Net Debt 45.6m / FCF TTM 32.3m)
Total Stockholder Equity = 148.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.50% (Net Income 47.2m / Total Assets 297.2m)
RoE = 31.81% (Net Income TTM 47.2m / Total Stockholder Equity 148.3m)
RoCE = 29.70% (EBIT 57.6m / Capital Employed (Equity 148.3m + L.T.Debt 45.6m))
RoIC = 22.66% (NOPAT 48.2m / Invested Capital 212.5m)
WACC = 8.72% (E(444.9m)/V(505.9m) * Re(9.70%) + D(61.0m)/V(505.9m) * Rd(1.90%) * (1-Tc(0.16)))
Discount Rate = 9.70% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -55.56 | Cagr: -8.78%
[DCF] Terminal Value 76.77% ; FCFF base≈27.3m ; Y1≈31.3m ; Y5≈46.0m
[DCF] Fair Price = 45.14 (EV 649.9m - Net Debt 45.6m = Equity 604.3m / Shares 13.4m; r=8.72% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.30 | EPS CAGR: 30.31% | SUE: 0.92 | # QB: 4
Revenue Correlation: 84.71 | Revenue CAGR: 6.98% | SUE: 1.72 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.86 | Chg30d=-1.70% | Revisions=-25% | Analysts=2
EPS current Year (2026-06-30): EPS=3.52 | Chg30d=+0.00% | Revisions=+25% | GrowthEPS=+28.0% | GrowthRev=+14.6%
EPS next Year (2027-06-30): EPS=3.62 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+3.0% | GrowthRev=+6.0%
[Analyst] Revisions Ratio: -17% (up=1, down=2)